SA
CLX icon

Sicart Associates’s Clorox CLX Stock Holding History

Sicart Associates’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.5M Sell
14,435
-770
-5% -$87.3K 0.38% 43
2025
Q4 		$1.53M Sell
15,205
-7,140
-32% -$775K 0.41% 41
2025
Q3 		$2.76M Hold
22,345
– – 0.75% 37
2025
Q2 		$2.68M Sell
22,345
-930
-4% -$124K 0.94% 35
2025
Q1 		$3.43M Sell
23,275
-10
-0% -$1.53K 1.19% 32
2024
Q4 		$3.78M Sell
23,285
-1,240
-5% -$203K 1.35% 30
2024
Q3 		$4M Hold
24,525
– – 1.4% 30
2024
Q2 		$3.35M Sell
24,525
-605
-2% -$84K 1.28% 32
2024
Q1 		$3.85M Sell
25,130
-460
-2% -$68.7K 1.41% 26
2023
Q4 		$3.65M Sell
25,590
-1,280
-5% -$171K 1.4% 27
2023
Q3 		$3.52M Buy
26,870
+1,103
+4% +$168K 1.38% 26
2023
Q2 		$4.1M Buy
25,767
+470
+2% +$75.8K 1.59% 24
2023
Q1 		$4M Sell
25,297
-3,420
-12% -$513K 1.56% 27
2022
Q4 		$4.03M Buy
28,717
+475
+2% +$67.4K 1.42% 26
2022
Q3 		$3.63M Sell
28,242
-205
-0.7% -$29.6K 1.29% 29
2022
Q2 		$4.01M Sell
28,447
-2,570
-8% -$367K 1.25% 28
2022
Q1 		$4.31M Sell
31,017
-40
-0.1% -$6.13K 1.12% 31
2021
Q4 		$5.35M Buy
31,057
+775
+3% +$129K 1.4% 24
2021
Q3 		$5.01M Buy
+30,282
New +$5.21M 1.37% 27

Other funds holding CLX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Sicart Associates's CLX Position: Q1 2026 in Review

Sicart Associates reduced its Clorox (CLX) stake by 5.1% in Q1 2026, selling an estimated $87.3K and leaving 14,435 shares worth $1.5M. The position accounts for 0.38% of the portfolio, ranked #43.

Sicart Associates first reported a position in CLX in Q3 2021 and has held it in 19 quarters since. The position peaked at $5.35M in Q4 2021. 1,082 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Sicart Associates held 14,435 shares of Clorox worth $1.5M as of Q1 2026.
  • Sicart Associates sold 770 Clorox shares in Q1 2026, an estimated $87.3K.
  • Clorox made up 0.38% of Sicart Associates's portfolio in Q1 2026, its #43 holding.
  • Sicart Associates first reported a position in Clorox in Q3 2021 and has held it in 19 quarters since.
  • Sicart Associates's Clorox position peaked at $5.35M in Q4 2021.
  • 1,082 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Sicart Associates's 13F filing for Q1 2026, filed 21 Apr 2026.